US 8124584
Macrocyclic hepatitis C serine protease inhibitors
granted A61KA61K38/12A61P
Quick answer
US patent 8124584 (Macrocyclic hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61K, A61K38/12, A61P, A61P31/12